Canadian-based medical cannabis producer Tilray and University of British Columbia have begun patient enrolment in Canada’s first Phase II clinical trial of medical cannabis to treat post-traumatic stress disorder (PTSD).

Cannabis plant belongs to the family of Cannabaceae of the nettle order, which is believed to be effective in soothing nausea, increase appetite, relieve pain and reduce epileptic seizures.

Claimed as one of the world’s first large-scale clinical trials, the Phase II, triple blind, placebo-controlled, randomised, crossover clinical trial is intended to determine the safety and efficacy of three potencies of medical cannabis to treat chronic, treatment-resistant PTSD symptoms resulting from a traumatic event.

"The trial will enrol 42 Canadians diagnosed with PTSD due to trauma faced during military service, as a first responder or police, or as the result of violence and / or sexual assault."

The trial will enrol 42 Canadians diagnosed with PTSD due to trauma faced during military service, as a first responder or police, or as the result of violence and / or sexual assault.

Tilray clinical research director Catherine Jacobson said: “We are providing physicians and researchers with cannabis-derived study drugs that meet rigorous regulatory standards for human trials, and which are based on studies indicating a high likelihood of success in treating specific diseases and disease-related symptoms.

“Methodologically sound research resulting from these trials is the best tool we can offer physicians to further understand the effectiveness of medical cannabis treatment for the myriad symptoms associated with conditions such as PTSD and epilepsy, as well as those stemming from other treatments such as chemotherapy.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Tilray has also partnered with The New South Wales (NSW) Government, the University of Sydney and Chris O`Brien Lifehouse in Australia to develop treatment for nausea and vomiting in chemotherapy.

Image: Cannabis sativa leaf. Photo: courtesy of JonRichfield.